Correlation Between Clearside Biomedical and Morgan Stanley

Can any of the company-specific risk be diversified away by investing in both Clearside Biomedical and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearside Biomedical and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clearside Biomedical and Morgan Stanley, you can compare the effects of market volatilities on Clearside Biomedical and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearside Biomedical with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearside Biomedical and Morgan Stanley.

Diversification Opportunities for Clearside Biomedical and Morgan Stanley

-0.14

Correlation Coefficient

Clearside Biomedical  Morgan Stanley

Good diversification

The 3 months correlation between Clearside and Morgan is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Clearside Biomedical and Morgan Stanley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley and Clearside Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearside Biomedical are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley has no effect on the direction of Clearside Biomedical i.e., Clearside Biomedical and Morgan Stanley go up and down completely randomly.

Pair Corralation between Clearside Biomedical and Morgan Stanley

Assuming the 90 days trading horizon Clearside Biomedical is expected to under-perform the Morgan Stanley. In addition to that, Clearside Biomedical is 3.15 times more volatile than Morgan Stanley. It trades about -0.07 of its total potential returns per unit of risk. Morgan Stanley is currently generating about 0.27 per unit of volatility. If you would invest  9,442  in Morgan Stanley on April 20, 2025 and sell it today you would earn a total of  2,708  from holding Morgan Stanley or generate 28.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Clearside Biomedical  vs.  Morgan Stanley

Clearside Biomedical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in August 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Morgan Stanley

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Morgan Stanley reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Clearside Biomedical and Morgan Stanley

The main advantage of trading using opposite Clearside Biomedical and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearside Biomedical position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.

The idea behind Clearside Biomedical and Morgan Stanley pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.